Press Releases
-
March 11, 2024
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m. ET. Live and archived webcasts of...
-
February 08, 2024
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
Full Year 2023 GAAP Revenues of $1.147 billion Full Year 2023 GAAP net loss of $20 million and GAAP net loss per diluted share of $0.45 Full Year 2023 Non-GAAP EBITDA of $138 million and Non-GAAP net income per diluted share of $1.91 Full Year 2023...
-
January 16, 2024
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2023, before market open on...
-
January 11, 2024
Omnicell Elects Eileen Voynick to Board of Directors
Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today...
-
December 03, 2023
Omnicell Showcases Outcomes-Centric Innovation at ASHP Midyear 2023
Robotics, Smart Devices, Software, and Expert Services Designed to Drive Enhanced Outcomes for Healthcare Providers Across the Care Continuum.
-
December 01, 2023
Omnicell Achieves HITRUST Implemented, 1-Year Certification to Manage Data Protection and Mitigate Cybersecurity Threats
HITRUST Implemented, 1-Year Certification validates Omnicell‘s commitment to managing cybersecurity risk and protecting sensitive information
-
November 27, 2023
Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35 th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00...
-
November 02, 2023
Baptist Health Engages Omnicell in an Effort to Enhance Pharmacy Care and Further Gain Control of Medication Supply Chain
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter 2023, before market open on Thursday, November 2,...
-
November 02, 2023
Omnicell Announces Third Quarter 2023 Results; Updates Fiscal Year 2023 Guidance and Announces Reduction in Force
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter 2023, before market open on Thursday, November 2,...
-
October 16, 2023
Omnicell to Release Third Quarter 2023 Financial Results on November 2, 2023
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter 2023, before market open on Thursday, November 2,...
-
August 23, 2023
Omnicell to Present at the 2023 Wells Fargo Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023 at 3:00 p.m. ET. Live and archived webcasts of the...
-
August 01, 2023
Omnicell Announces Second Quarter 2023 Results
Total GAAP revenues of $299 million GAAP net income per diluted share of $0.08 Non-GAAP net income per diluted share of $0.57 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the...
-
July 12, 2023
Omnicell to Release Second Quarter 2023 Financial Results on August 1, 2023
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter 2023, after market close on Tuesday, August 1,...
-
July 11, 2023
Omnicell Appoints Bobby Ghoshal to Board of Directors
Established Leader Brings Global SaaS and Healthcare Technology Experience to Board Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced it has increased its number of...
-
May 30, 2023
Omnicell Announces Leadership and Organizational Changes
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced changes to its leadership structure designed to create a more streamlined organization with a continued focus on...
-
May 15, 2023
Omnicell Appoints Nchacha E. Etta as Executive Vice President and Chief Financial Officer
Seasoned Leader Brings Over Two Decades of Finance and Accounting Experience to Omnicell Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that Nchacha E. Etta has...